IL-9 is a new cytokine expressed by microglia and CD4+ T cells in lesions localized in both gray and white matter, as well as in inflamed meninges of MS patients, and its receptor, IL-9R, is expressed by macrophages/microglia in the areas IL-9+ of the CNS. This evidence concerns the gene IL9R and myeloid sarcoma.